全文获取类型
收费全文 | 1617篇 |
免费 | 69篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 36篇 |
妇产科学 | 16篇 |
基础医学 | 223篇 |
口腔科学 | 33篇 |
临床医学 | 141篇 |
内科学 | 300篇 |
皮肤病学 | 21篇 |
神经病学 | 159篇 |
特种医学 | 125篇 |
外科学 | 294篇 |
综合类 | 14篇 |
预防医学 | 63篇 |
眼科学 | 60篇 |
药学 | 79篇 |
中国医学 | 2篇 |
肿瘤学 | 96篇 |
出版年
2023年 | 20篇 |
2022年 | 37篇 |
2021年 | 44篇 |
2020年 | 27篇 |
2019年 | 26篇 |
2018年 | 51篇 |
2017年 | 31篇 |
2016年 | 46篇 |
2015年 | 38篇 |
2014年 | 55篇 |
2013年 | 91篇 |
2012年 | 104篇 |
2011年 | 106篇 |
2010年 | 56篇 |
2009年 | 48篇 |
2008年 | 105篇 |
2007年 | 112篇 |
2006年 | 83篇 |
2005年 | 101篇 |
2004年 | 82篇 |
2003年 | 86篇 |
2002年 | 76篇 |
2001年 | 16篇 |
2000年 | 14篇 |
1999年 | 11篇 |
1998年 | 12篇 |
1997年 | 10篇 |
1996年 | 9篇 |
1995年 | 8篇 |
1994年 | 6篇 |
1993年 | 7篇 |
1992年 | 6篇 |
1990年 | 8篇 |
1989年 | 5篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1978年 | 4篇 |
1975年 | 4篇 |
1974年 | 7篇 |
1933年 | 14篇 |
1931年 | 4篇 |
1930年 | 5篇 |
1913年 | 4篇 |
1912年 | 6篇 |
1911年 | 4篇 |
1884年 | 3篇 |
1883年 | 5篇 |
1881年 | 3篇 |
1880年 | 5篇 |
1879年 | 6篇 |
排序方式: 共有1690条查询结果,搜索用时 15 毫秒
21.
Summary In the irreversible stage of lymphedema corrective surgery is often mandatory. A choice has to be made between two different basic selective procedures. As no totally satisfactory surgical method has as yet been established surgical management is difficult and implies considerable personal responsibility. This is a report on the long-term results of operations carried out on 16 patients between 1958 and 1979 using the so called Charles procedure. It concludes that this radical operation gives an acceptable long-term result in long-standing, elephantiastic primary lymphedema of the lower extremity. 相似文献
22.
Kurt Krejcy Gunther Krumpl Hannes Todt Gerhard Raberger 《Naunyn-Schmiedeberg's archives of pharmacology》1992,346(2):213-218
Summary The aim of the present study was to investigate the dose-dependent antiarrhythmic efficacy of lidocaine against electrically induced tachycardias in conscious, chronically instrumented postinfarction dogs. Programmed electrical stimulation (PES) was performed in 16 dogs 8 to 21 days after a 4 h occlusion of the left anterior descending coronary artery (LAD). Infusion of saline in 8 control animals with sustained ventricular tachycardia (SVT) inducible at baseline did not affect subsequent inducibility. In the treatment group 7 of 8 animals responded with SVT and one exhibited ventricular fibrillation at baseline. After an initial bolus of 1 mg/kg lidocaine intravenously (i.v.), the drug was infused at infusion rates of 40, 80 and 120 g/kg/min (i.v.). During 80 g/kg/min lidocaine (mean plasma level 3.5 g/ml) 7 out of 8 animals displayed an antiarrhythmic response; both the lower and the higher infusion rate were associated with a smaller antiarrhythmic efficacy (3 of 8 animals responded to 40 g/kg/min and 4 of 8 to 120 g/kg/min). Licocaine did not affect ventricular refractory periods, but induced an increase in intraventricular conduction time at all infusion rates, from 66.2 ms at baseline to 67.7 ms (p<0.05), 67.7 ms (p<0.05), 70.0 ms (p<0.01) respectively.In conclusion the present study demonstrates that lidocaine is of considerable value in the management of PES-induced ventricular arrhythmias in the postinfarction phase. However there is only a small optimal therapeutic plasma level range, where lidocaine exhibits its antiarrhythmic efficacy against this type of arrhythmia; this makes a carefully titration of the drug necessary both in the experimental and in the clinical setting.
Send offprint requests to K. Krejcy at the above address 相似文献
23.
Heidi Fiegl Conny Gattringer Andreas Widschwendter Alois Schneitter Angela Ramoni Daniela Sarlay Inge Gaugg Georg Goebel Hannes M Müller Elisabeth Mueller-Holzner Christian Marth Martin Widschwendter 《Cancer epidemiology, biomarkers & prevention》2004,13(5):882-888
This proof of principle study aimed to define a new and simple strategy for detection of endometrial cancer using epigenetic markers. We investigated DNA isolated from vaginal secretion collected from tampon for aberrant methylation of five genes (CDH13, HSPA2, MLH1, RASSF1A, and SOCS2) using MethyLight in 15 patients with endometrial cancer and 109 patients without endometrial cancer. All endometrial cancer patients revealed three or more methylated genes, whereas 91% (99 of 109) of the patients without endometrial cancer had no or fewer than three genes methylated in their vaginal secretion. The methods developed in this study provide the basis for a prospective clinical trial to screen asymptomatic women who are at high risk for endometrial cancer. 相似文献
24.
Rainov Nikolai G. Dobberstein Karl-Ulrich Bahn Hannes Holzhausen Hans-Jürgen Lautenschläger Christine Heidecke Volkmar Burkert Winfried 《Journal of neuro-oncology》1997,35(1):13-28
Despite the use of multimodal therapy, higher-grade glioma is stilluniformly fatal in the adult population. There is a considerable differencebetween the length of survival in each given patient, even within the sametumor type and malignancy grade group, suggesting that there are factorsthat might differentially influence outcome. To identify such factors, 107patients with anaplastic or malignant glioma were retrospectivelyinvestigated. Clinical parameters and paraclinical data on the p53, mdm2,and EGFR genes at the DNA or protein level were evaluated by univariateanalysis and Cox proportional hazards regression modeling. Kaplan-Meiersurvival estimation demonstrated that immunohistochemical positivity formdm2 protein in patients with anaplastic astrocytoma or with glioblastomamultiforme was associated with a shorter survival time (p = 0.02).P53 gene mutations and immunopositivity for the epidermal growth factorreceptor (EGFR) protein were not significantly related to poor prognosis.The Cox proportional hazards model revealed immunohistochemical positivityfor p53, mdm2, or for both of them, the presence of postoperativeirradiation, and the extent of surgical resection of tumor to be variablessignificantly associated with prolonged survival. EGFR overexpression, ageover 60 years, and Karnofsky performance score below 40 points did notsignificantly shorten survival time. In conclusion, the present studyidentified immunohistochemically detected mdm2-protein overexpression as astatistically significant negative prognostic parameter in patients bearinganaplastic or malignant glioma. Association analysis of variables revealed apossible correlation between mdm2 and p53, which is also consistent with thebiological interaction mode of both proteins in vivo. 相似文献
25.
Katarina Nemec Hannes Schihada Gunnar Kleinau Ulrike Zabel Eugene O. Grushevskyi Patrick Scheerer Martin J. Lohse Isabella Maiellaro 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(32)
Receptor-activity-modifying proteins (RAMPs) are ubiquitously expressed membrane proteins that associate with different G protein–coupled receptors (GPCRs), including the parathyroid hormone 1 receptor (PTH1R), a class B GPCR and an important modulator of mineral ion homeostasis and bone metabolism. However, it is unknown whether and how RAMP proteins may affect PTH1R function. Using different optical biosensors to measure the activation of PTH1R and its downstream signaling, we describe here that RAMP2 acts as a specific allosteric modulator of PTH1R, shifting PTH1R to a unique preactivated state that permits faster activation in a ligand-specific manner. Moreover, RAMP2 modulates PTH1R downstream signaling in an agonist-dependent manner, most notably increasing the PTH-mediated Gi3 signaling sensitivity. Additionally, RAMP2 increases both PTH- and PTHrP-triggered β-arrestin2 recruitment to PTH1R. Employing homology modeling, we describe the putative structural molecular basis underlying our functional findings. These data uncover a critical role of RAMPs in the activation and signaling of a GPCR that may provide a new venue for highly specific modulation of GPCR function and advanced drug design.G protein–coupled receptors(GPCRs) represent the largest class of membrane-bound proteins and are involved in a multitude of biological processes (1). They are characterized by a seven-transmembrane helix structure, which undergoes a characteristic rearrangement upon binding of agonists. Agonist binding to its cognate receptor induces conformational changes in the transmembrane helices, which are transmitted to the cytosolic face of the receptors and ultimately result in receptor activation, which represents the key step of signal transduction. The combination of crystallographic and cryogenic electron microscopy studies and the employment of optical biosensors to study the reorganization of the seven transmembrane domains has allowed a detailed understanding of the general mechanisms of GPCR activation (2–5).Earlier structural studies suggest that GPCRs undergo similar conformational changes upon activation, including, most prominently, an outward movement of the transmembrane helix 6 at the cytosolic face, thereby creating a pocket to which the G protein α-subunit can couple (5). More recent studies, however, have revealed that the exact type of changes may depend on the receptor class and the specific receptor (6–8). Class- and receptor-specific differences may also exist in the interaction of receptors not only with downstream G proteins and β-arrestins but also with accessory and modulatory proteins (9).Studies of the kinetic steps that govern the structural rearrangements which underlie receptor activation (10) showed that its speed might depend on the receptor class and the specific receptor. For example, when exposed to saturating agonist concentrations, most class A GPCRs switch into the active state within tens of milliseconds. The same process takes 1 to 2 ms for a class C GPCR and may take up to a second for class B receptors (11–15). Little is known whether the activation kinetics of GPCRs can be modulated by their cellular context and whether proteins other than the receptors themselves might play a role in shaping signaling kinetics and specificity.Here, we study the parathyroid hormone 1 receptor (PTH1R), a prototypical member of class B GPCRs characterized by a large N-terminal domain that binds a major part of their cognate peptide agonists (16, 17). Compared to class A GPCRs, PTH1R activation is relatively slow and occurs in a two-step process: The initial N-terminal binding step has a time constant of ∼140 ms, followed by an interaction of the ligand with the transmembrane core, which changes into its active conformation with a time constant of ∼1 s (11, 14). Pleiotropic in its downstream coupling, PTH1R signals primarily via Gs but can also couple to Gq (18), G12/13 (19), and Gi (20) and interacts with and signals via β-arrestins (21, 22). The two endogenous agonists, parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP), trigger PTH1R activation with similar kinetics and specificity for the various intracellular pathways (23–25). However, PTH can induce prolonged signaling from intracellular sites, while PTHrP signals exclusively from the cell surface (26).PTH1R has been reported to interact with modulatory proteins of the receptor-activity-modifying protein (RAMP) family (27–29). RAMPs constitute a family of single transmembrane helix proteins with three members: RAMP1, RAMP2, and RAMP3.It is controversial whether PTH1R interacts only or preferentially with RAMP2 (28) or all three RAMPs (28, 29). In RAMP2 knock-out mice, PTH1R function is deregulated, and placental dysfunction is observed (30), suggesting a major physiological role of the PTH1R/RAMP2 interaction. Yet, the molecular mechanisms of how RAMPs may modulate the activation dynamics of PTH1R and their signaling properties remain to be elucidated.To address these questions, we develop and employ biosensors for PTH1R activation and investigate an array of downstream signaling pathways to assess the effects of RAMPs on the activation dynamics and signaling properties of PTH1R in response to its two endogenous ligands, PTH and PTHrP. We observe that RAMP2 specifically interacts with PTH1R and modulates its activation kinetics as well as signaling dynamics in an agonist-dependent manner. 相似文献
26.
Heim K Hudelist G Geier A Szedenik H Christensen ND Concin N Bergant A Volgger B Czerwenka K Höpfl R 《Reproductive sciences (Thousand Oaks, Calif.)》2007,14(8):806-814
Type-specific antibodies to human papillomaviruses (HPVs) can be detected in most infected adult patients, and they have virus-neutralizing properties. However, there is a dearth of information on the seroprevalence of maternal and neonatal antibodies to HPV capsid antigens. Sera from 104 mothers, their newborns, and 3 twin pregnancies were analyzed by an enzyme-linked immunosorbent assay (ELISA) for the presence of specific IgG, IgM, and IgA antibodies to virus-like particles of HPV-6, -11, -16, -18, and -31. Maternal IgG positivity rates to HPV types 6, 11, 16, 18, and 31 were 23.1%, 2.9%, 8.7%, 5.8%, and 9.6%, respectively. Neonatal rates did not differ significantly, and individual IgG ELISA values of mothers and their infants and all paired twins showed a very high correlation. In contrast, nearly all IgM and IgA individual values in newborns were designated negative, whereas mothers' positivity rates ranged as high as 19.2%. Infants showed no HPV-related lesions at birth or at 4-year follow-up. Seven of 8 tested children lost IgG HPV antibodies in a follow-up examination. Similar anti-HPV IgG seropositivity in mothers and newborns and a lack of neonatal IgA and IgM together with twin and follow-up results indicate that neonatal IgG is not a sign of intrauterine HPV infection but, rather, maternofetal antibody transmission. 相似文献
27.
Simons Pickhan Englmann A. Laqueur Halberstädter Alb Simons Zuppinger E. Goldberger Walther Hannes 《Journal of cancer research and clinical oncology》1931,34(5):196-208
Ohne Zusammenfassung 相似文献
28.
Max Winkler Fritz Juliusberg Max Joseph Theodor Baer J. Ullmann Leiner Theodor Schwab Walther Pick M. Oppenheim F. Münchheimer Leopold Arzt Weiler Ludwig Zweig Alfred Roth V. Lion Marg Stern Hannes Ernest Spitzer F. Krzysztalowicz Max Leibkind H. Hanf H. Fuchs Odstrčil Starke E. Spitzer Ernst Spitzer Viktor Bandler F. Lewandowsky Max Winkler 《Archives of dermatological research》1915,122(2):188-248
Ohne Zusammenfassung 相似文献
29.
30.
Hannes 《Archives of dermatological research》1912,112(7):886-888
Ohne Zusammenfassung 相似文献